Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Colorcon
McKinsey
Mallinckrodt
Express Scripts

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Cisplatin - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for cisplatin and what is the scope of patent protection?

Cisplatin is the generic ingredient in three branded drugs marketed by Accord Hlthcare, Bedford, Fresenius Kabi Usa, Gland Pharma Ltd, Hq Spclt Pharma, Mylan Labs Ltd, Pharmachemie Bv, Teva Pharms Usa, and West-ward Pharms Int, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for cisplatin. Nine suppliers are listed for this compound.

Drug Prices for cisplatin

See drug prices for cisplatin

Recent Clinical Trials for cisplatin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of RussiaPhase 2
Wuhan UniversityPhase 3
GuiZhou Province Tumor HospitalPhase 3

See all cisplatin clinical trials

Recent Litigation for cisplatin

Identify potential future generic entrants

District Court Litigation
Case NameDate
Pharmacia & Upjohn v. Sicor Inc.2004-07-08

See all cisplatin litigation

Pharmacology for cisplatin
Medical Subject Heading (MeSH) Categories for cisplatin
Paragraph IV (Patent) Challenges for CISPLATIN
Tradename Dosage Ingredient NDA Submissiondate
CISPLATIN INJECTABLE;INJECTION cisplatin 018057
PLATINOL INJECTABLE;INJECTION cisplatin 018057
PLATINOL-AQ INJECTABLE;INJECTION cisplatin 018057

US Patents and Regulatory Information for cisplatin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare CISPLATIN cisplatin INJECTABLE;INJECTION 206774-001 Aug 18, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
West-ward Pharms Int CISPLATIN cisplatin INJECTABLE;INJECTION 075036-001 Nov 7, 2000 AP RX No No   Start Trial   Start Trial   Start Trial
Hq Spclt Pharma PLATINOL-AQ cisplatin INJECTABLE;INJECTION 018057-003 Jul 18, 1984 DISCN Yes No   Start Trial   Start Trial   Start Trial
Mylan Labs Ltd CISPLATIN cisplatin INJECTABLE;INJECTION 091062-001 Apr 18, 2012 AP RX No No   Start Trial   Start Trial   Start Trial
Hq Spclt Pharma PLATINOL cisplatin INJECTABLE;INJECTION 018057-002 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Gland Pharma Ltd CISPLATIN cisplatin INJECTABLE;INJECTION 207323-001 Mar 17, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for cisplatin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hq Spclt Pharma PLATINOL cisplatin INJECTABLE;INJECTION 018057-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Hq Spclt Pharma CISPLATIN cisplatin INJECTABLE;INJECTION 018057-004 Nov 8, 1988   Start Trial   Start Trial
Hq Spclt Pharma PLATINOL-AQ cisplatin INJECTABLE;INJECTION 018057-003 Jul 18, 1984   Start Trial   Start Trial
Hq Spclt Pharma PLATINOL-AQ cisplatin INJECTABLE;INJECTION 018057-003 Jul 18, 1984   Start Trial   Start Trial
Hq Spclt Pharma PLATINOL cisplatin INJECTABLE;INJECTION 018057-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Hq Spclt Pharma PLATINOL cisplatin INJECTABLE;INJECTION 018057-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Dow
Boehringer Ingelheim
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.